TB500 (Thymosin B4 Acetate)

Here's the reworded version with all quantity/milligram references removed:

TB500 Thymosin Beta-4 Acetate Research Peptide

This Thymosin Beta-4 acetate formulation is designed to support expanded preclinical research programs examining immunomodulatory peptide mechanisms. The supply format accommodates extended in vitro protocols, tissue culture investigations, and animal model studies requiring sustained compound availability throughout the duration of investigation.

TB500 Thymosin Beta-4 Acetate — Peptide Identification & Structure

TB500 is composed of a 43-amino acid sequence with an approximate molecular weight of 4,963 Da. The acetate salt formulation is selected for its improved pharmaceutical stability and enhanced aqueous solubility under research conditions. Natural sources of Thymosin Beta-4 include thymic tissue and circulating white blood cells in mammalian systems.

TB500 Thymosin Beta-4 Acetate — Mechanism of Action

Preclinical investigation indicates that TB500 binds actin monomers, sequestering actin and modulating polymerization dynamics central to cellular cytoskeletal function. In vitro models have demonstrated TB500-dependent changes in cell migration behavior, wound closure rates in tissue culture systems, and inflammatory cytokine regulation in stimulated immune cell preparations.

TB500 Thymosin Beta-4 Acetate — Research Background

Published scientific literature documents TB500 activity across several research domains. Studies appearing in Molecular Medicine Reports have characterized actin-regulatory mechanisms in cell culture settings. Animal-based research published in Inflammation Research has further documented TB500's effects on pro-inflammatory mediator production, edema formation, and tissue response patterns. The broader body of literature supports continued investigation of TB500 within regenerative medicine research models.

TB500 Thymosin Beta-4 Acetate — Product Specifications & Handling

• Form: Lyophilized acetate powder

• Purity: Research-grade, ≥98%

• Storage: Optimal at −20°C, protected from light and moisture

• Reconstitution: Bacteriostatic saline or sterile water; allow equilibration to room temperature prior to use

• Post-Reconstitution Stability: 2–3 weeks when refrigerated

Research Use Only

TB500 is designated exclusively for preclinical research, in vitro studies, and controlled laboratory investigation. It is not approved for human consumption, animal treatment, or clinical application. All use must comply with applicable institutional research standards and regulatory requirements.